Next generation sequencing for molecular diagnosis of neuromuscular diseases.
about
Identifying Children With Poor Cochlear Implantation Outcomes Using Massively Parallel Sequencing.Assessment of a targeted resequencing assay as a support tool in the diagnosis of lysosomal storage disorders.MotorPlex provides accurate variant detection across large muscle genes both in single myopathic patients and in pools of DNA samples.Exome analysis of two limb-girdle muscular dystrophy families: mutations identified and challenges encounteredProgress and prospects of gene therapy clinical trials for the muscular dystrophies.Muscle histopathology in nebulin-related nemaline myopathy: ultrastrastructural findings correlated to disease severity and genotype.VaRank: a simple and powerful tool for ranking genetic variantsMolecular and clinical study of a cohort of 110 Algerian patients with autosomal recessive ataxia.Expanding genotype/phenotype of neuromuscular diseases by comprehensive target capture/NGS.A first-line diagnostic assay for limb-girdle muscular dystrophy and other myopathies.Increasing Role of Titin Mutations in Neuromuscular Disorders.Diagnostic use of Massively Parallel Sequencing in Neuromuscular Diseases: Towards an Integrated Diagnosis.Impacts of massively parallel sequencing for genetic diagnosis of neuromuscular disorders.Neuromuscular disorders in zebrafish: state of the art and future perspectives.The emerging agenda of stratified medicine in neurology.A rising titan: TTN review and mutation update.Next generation sequencing and array-based comparative genomic hybridization for molecular diagnosis of pediatric endocrine disorders.Next generation sequencing (NGS) strategies for the genetic testing of myopathies.Reply: Hereditary myopathy with early respiratory failure is caused by mutations in the titin FN3 119 domain.Hereditary myopathy with early respiratory failure is caused by mutations in the titin FN3 119 domain.Validation of a next-generation sequencing assay for clinical molecular oncology.Hereditary myopathy with early respiratory failure: occurrence in various populations.Muscular dystrophies and myopathies: the spectrum of mutated genes in the Czech Republic.Exome sequencing identifies a novel TTN mutation in a family with hereditary myopathy with early respiratory failure.Necklace cytoplasmic bodies in hereditary myopathy with early respiratory failure.Novel findings with reassessment of exome data: implications for validation testing and interpretation of genomic data.Neuropathology training worldwide-evolution and comparisons.Interpreting Genetic Variants in Titin in Patients With Muscle Disorders.New massive parallel sequencing approach improves the genetic characterization of congenital myopathies.Targeted Re-Sequencing Emulsion PCR Panel for Myopathies: Results in 94 Cases.Novel Variants in Individuals with RYR1-Related Congenital Myopathies: Genetic, Laboratory, and Clinical Findings.Validation of Ion TorrentTM Inherited Disease Panel with the PGMTM Sequencing Platform for Rapid and Comprehensive Mutation Detection.
P2860
Q30405367-804955CF-2AAD-4DDE-A538-99F1E1E6671AQ33624239-31915F13-2B54-46A6-8428-7F4A43988197Q34234134-A6532A2B-B2A2-46DA-AC40-FB29EF24501BQ34479143-7A802E86-9311-4B83-A8FA-BB2888A2F705Q34497471-61C3EE97-D290-4ADB-9630-84396538BEABQ34528684-5C4E25FB-DDFB-4FD0-ABFA-19FC42A9C5F5Q35174096-4BA2A183-61F1-48C9-994C-FA805B3E0A40Q35661835-7BEB0E03-FFAE-4691-91B5-425FC68A761AQ36729177-3858F1D0-DC7F-441B-A467-A6EA9C47B257Q37286757-C0CF141D-838A-4789-B024-B4E0CBEF0DEAQ37441312-06FBA90F-EEDB-4DF3-BE40-8892FF02625AQ37589634-E39AFE32-29F5-440A-A557-62A882B85826Q38065979-29C150B1-B101-475F-AD5D-5C055ABD85E4Q38098929-645454E2-C29A-4AEB-B7C8-47DFD2E8BB62Q38169977-4ED0EEC6-4DA5-4930-BBE1-D5D2BFEFDACAQ38224878-5E9EFE77-AD3A-479E-95DA-8C192C6AC991Q39424944-DEC9A4A6-171C-4D6A-A108-B2C930CD2096Q39980386-F9EE77DC-C9FB-4A2E-B739-72F2BB704441Q43922742-C49FFA4A-F6AE-42B0-A509-26109EE8EDACQ44099917-880BEFB5-09A8-4A6F-BE47-0A146509C1EAQ45823548-C29C84E3-A57F-4DFD-BE2F-8EEBFE8DA557Q45838995-722DE6D4-4199-4EAB-80D9-C1760CBBB170Q45856675-C56652C4-74C0-4A05-A7F9-9BD055CBFD90Q45934258-4F10340B-B5A4-49AC-84A1-31CD256B92A0Q48266921-58CE06FD-4395-4B26-B400-31ADDD5539CFQ48516627-26B90B58-6D42-483C-BEEA-A07541FEEC94Q48862651-0F76BAE6-622A-4081-B339-F42A66A837E0Q49025523-1574A5BB-019C-4C2C-A113-9C45AFC73EF4Q50883940-4AF1F199-1C3E-46BC-9156-B618C410FAA7Q51063227-6B159905-755E-4E7B-AACF-5BB1BEE7DF84Q52647770-293E8DE7-1C2E-452B-B775-597956E7935DQ55313660-C82CB9D7-A8D6-4A27-B9C5-04E9F90AE5A4
P2860
Next generation sequencing for molecular diagnosis of neuromuscular diseases.
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Next generation sequencing for molecular diagnosis of neuromuscular diseases.
@ast
Next generation sequencing for molecular diagnosis of neuromuscular diseases.
@en
Next generation sequencing for molecular diagnosis of neuromuscular diseases.
@nl
type
label
Next generation sequencing for molecular diagnosis of neuromuscular diseases.
@ast
Next generation sequencing for molecular diagnosis of neuromuscular diseases.
@en
Next generation sequencing for molecular diagnosis of neuromuscular diseases.
@nl
prefLabel
Next generation sequencing for molecular diagnosis of neuromuscular diseases.
@ast
Next generation sequencing for molecular diagnosis of neuromuscular diseases.
@en
Next generation sequencing for molecular diagnosis of neuromuscular diseases.
@nl
P2093
P2860
P50
P1476
Next generation sequencing for molecular diagnosis of neuromuscular diseases
@en
P2093
Andoni Echaniz-Laguna
Bernard Jost
Frédéric Plewniak
Jamel Chelly
Jocelyn Laporte
Nasim Vasli
Rafaelle Bernard
Serge Vicaire
Stéphanie Le Gras
Valérie Biancalana
P2860
P2888
P304
P356
10.1007/S00401-012-0982-8
P577
2012-04-18T00:00:00Z
P5875
P6179
1015484810